| Literature DB >> 34948974 |
Michael John Norton1,2, Claire Flynn3.
Abstract
Wellness Recovery Action Planning (WRAP) is a structured recovery education program used internationally for anyone who wishes to create a positive change in their life. It was developed by Mary Ellen Copeland and Jane Winterling in the late 90s, resulting from a search of programs or initiatives that could support their wellness. Since then, many studies have been conducted into the efficacy of the program for those with a mental health/addiction challenge. However, to date, there has been little to no synthesis of the evidence base for WRAP outside of the Copeland Center's internal reviews. The proposed systematic review and meta-analysis aims to investigate the evidence base for Wellness Recovery Action Planning within a mental health context. To do this, a PRISMA 2020 compliant review is proposed using the PRISMA-P statement as a guide to demonstrate the methodology to be undertaken. It outlines the inclusion/exclusion criteria, search terms, and databases while informing the readership of timescales to complete such actions. Finally, this protocol also addresses issues of bias and quality within included studies. This proposed literature review and meta-analysis will synthesize and examine the evidence base for WRAP using a systematic review methodology. It is hoped that this proposed review will identify gaps in the current literature regarding the program, and provide recommendations that will support the reviewers in their further studies while also strengthening the argument for a whole system evaluation of WRAP within an Irish context.Entities:
Keywords: WRAP; mental health; recovery; recovery education; recovery orientation
Mesh:
Year: 2021 PMID: 34948974 PMCID: PMC8705466 DOI: 10.3390/ijerph182413365
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
PRISMA-P (Preferred Reporting Items for Systematic review and Meta-Analysis Protocols) 2015 checklist: recommended items to address in a systematic review protocol *.
| Section and Topic | Item No | Checklist Item | Achieved? |
|---|---|---|---|
|
| |||
| Title: | |||
| Identification | 1a | Identify the report as a protocol of a systematic review | YES |
| Update | 1b | If the protocol is for an update of a previous systematic review, identify as such | N/A |
| Registration | 2 | If registered, provide the name of the registry (such as PROSPERO) and registration number | YES |
| Authors: | |||
| Contact | 3a | Provide name, institutional affiliation, e-mail address of all protocol authors; provide physical mailing address of corresponding author | YES |
| Contributions | 3b | Describe contributions of protocol authors, and identify the guarantor of the review | YES |
| Amendments | 4 | If the protocol represents an amendment of a previously completed or published protocol, identify as such, and list changes; otherwise, state plan for documenting important protocol amendments | N/A |
| Support: | |||
| Sources | 5a | Indicate sources of financial or other support for the review | N/A |
| Sponsor | 5b | Provide name for the review funder and/or sponsor | N/A |
| Role of sponsor or funder | 5c | Describe roles of funder(s), sponsor(s), and/or institution(s), if any, in developing the protocol | N/A |
|
| |||
| Rationale | 6 | Describe the rationale for the review in the context of what is already known | YES |
| Objectives | 7 | Provide an explicit statement of the question(s) the review will address with reference to participants, interventions, comparators, and outcomes (PICO) | YES |
|
| |||
| Eligibility criteria | 8 | Specify the study characteristics (such as PICO, study design, setting, time frame) and report characteristics (such as years considered, language, publication status) to be used as criteria for eligibility for the review | YES |
| Information sources | 9 | Describe all intended information sources (such as electronic databases, contact with study authors, trial registers or other gray literature sources) with planned dates of coverage | YES |
| Search strategy | 10 | Present draft of search strategy to be used for at least one electronic database, including planned limits, such that it could be repeated | YES |
| Study records: | |||
| Data management | 11a | Describe the mechanism(s) that will be used to manage records and data throughout the review | YES |
| Selection process | 11b | State the process that will be used for selecting studies (such as two independent reviewers) through each phase of the review (that is, screening, eligibility, and inclusion in meta-analysis) | YES |
| Data collection process | 11c | Describe planned method of extracting data from reports (such as piloting forms, done independently, in duplicate), any processes for obtaining and confirming data from investigators | YES |
| Data items | 12 | List and define all variables for which data will be sought (such as PICO items, funding sources), any pre-planned data assumptions and simplifications | YES |
| Outcomes and prioritization | 13 | List and define all outcomes for which data will be sought, including prioritization of main and additional outcomes, with rationale | N/A |
| Risk of bias in individual studies | 14 | Describe anticipated methods for assessing risk of bias of individual studies, including whether this will be done at the outcome or study level, or both; state how this information will be used in data synthesis | YES |
| Data synthesis | 15a | Describe criteria under which study data will be quantitatively synthesised | YES |
| 15b | If data are appropriate for quantitative synthesis, describe planned summary measures, methods of handling data, and methods of combining data from studies, including any planned exploration of consistency (such as I2, Kendall’s τ) | YES | |
| 15c | Describe any proposed additional analyses (such as sensitivity or subgroup analyses, meta-regression) | N/A | |
| 15d | If quantitative synthesis is not appropriate, describe the type of summary planned | YES | |
| Meta-bias(es) | 16 | Specify any planned assessment of meta-bias(es) (such as publication bias across studies, selective reporting within studies) | YES |
| Confidence in cumulative evidence | 17 | Describe how the strength of the body of evidence will be assessed (such as GRADE) | N/A |
* It is strongly recommended that this checklist be read in conjunction with the PRISMA-P Explanation and Elaboration (cite when available) for important clarification on the items. Amendments to a review protocol should be tracked and dated. The copyright for PRISMA-P (including checklist) is held by the PRISMA-P Group, and is distributed under a Creative Commons Attribution License 4.0.
Inclusion/exclusion criteria.
| Inclusion | Exclusion |
|---|---|
| Peer Reviewed Qualitative, Quantitative, and Mixed Method Articles | Editorials, Media Articles, Opinion Pieces, Gray Literature (Published Study), Systematic Reviews, Literature Reviews, Rapid Reviews, Meta-Analysis, Meta-Synthesis |
| Dissertations | |
| English Language | |
| Articles within Past 10 Years | |
| WRAP in Adulthood | WRAP in Children/Adolescence |
| WRAP for Mental Health | WRAP for Addictions/Physical Health, Intellectual Disability/Dual Diagnosis |
| Individual WRAP | Family WRAP |
Figure 1PRISMA 2020 flow diagram.